...I still can't believe all those that continue to not see the intrinsic value, which will become astronomical in value
Biopharm, these days there are many more not seeing the intrinsic value than those who do, true. But when terms like "astronomical" are thrown out there by a CEO who doesn't even know the importance of shareholder value it is concerning. Less than $250 Million valuation of a manufacturing branch, roughly $50-60 Million cash and supposedly life-changing technology. And a CEO who doesn't give a dead mouse's behind about it's shareholder.